Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 10, 2024 FORM 4
ARS Jun 28, 2024 ARS
DEFA14A Jun 26, 2024 DEFA14A
DEF 14A Jun 26, 2024 DEF 14A
10-K May 29, 2024 10-K
8-K May 29, 2024 8-K
4 May 24, 2024 FORM 4
4 May 24, 2024 FORM 4
4 May 24, 2024 FORM 4
4 May 24, 2024 FORM 4
4 May 24, 2024 FORM 4
4 Apr 26, 2024 FORM 4
4 Apr 26, 2024 FORM 4
4 Apr 26, 2024 FORM 4
4 Apr 19, 2024 FORM 4
4 Apr 19, 2024 FORM 4
4 Apr 19, 2024 FORM 4
4 Apr 19, 2024 FORM 4
4 Apr 19, 2024 FORM 4
S-8 Apr 15, 2024 S-8
4 Apr 10, 2024 FORM 4
4 Apr 10, 2024 FORM 4
4 Apr 10, 2024 FORM 4
4 Apr 4, 2024 FORM 4
4 Apr 4, 2024 FORM 4
← Newer Page 9 of 26 · 641 filings Older →